Stay updated on Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The site now reports 607,349 studies, up from 606,601, across all 50 states and 226 countries and territories. The displayed site revision also advanced from v3.7.1 to v3.7.2.
    Difference
    0.4%
    Check dated 2026-10-18T01:47:10.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The homepage now reports 606,601 studies across the listed locations, up from 605,599. The site revision is updated from v3.7.0 to v3.7.1.
    Difference
    0.4%
    Check dated 2026-10-11T02:18:12.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The listed study count increased from 604,566 to 605,599, while the geographic coverage remained the same.
    Difference
    0.1%
    Check dated 2026-10-04T02:07:59.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    On the homepage, the text now specifies that ClinicalTrials.gov covers 604,566 studies and spans all 50 states and 226 countries and territories. This replaces the earlier incomplete line, clarifying the scope of studies accessible through the site.
    Difference
    0.1%
    Check dated 2026-09-27T02:11:30.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The exact count of studies text was replaced with a generic statement about ClinicalTrials.gov covering locations across all 50 states and countries, and the release version was updated from v3.6.6 to v3.7.0.
    Difference
    0.3%
    Check dated 2026-09-20T01:23:06.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The homepage now shows 602,520 studies, up from 601,694, reflecting an expansion in the registered studies listed on the site.
    Difference
    0.1%
    Check dated 2026-09-13T00:14:26.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial page.